Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America

We previously showed that Month 13 50% plaque reduction neutralization test (PRNT(50)) neutralizing antibody (nAb) titers against dengue virus (DENV) correlated with vaccine efficacy (VE) of CYD-TDV against symptomatic, virologically-confirmed dengue (VCD) in the CYD14 and CYD15 Phase 3 trials. Whil...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS One
Κύριοι συγγραφείς: Carpp, Lindsay N., Fong, Youyi, Bonaparte, Matthew, Moodie, Zoe, Juraska, Michal, Huang, Ying, Price, Brenda, Zhuang, Yingying, Shao, Jason, Zheng, Lingyi, Chambonneau, Laurent, Small, Robert, Sridhar, Saranya, DiazGranados, Carlos A., Gilbert, Peter B.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2020
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295445/
https://ncbi.nlm.nih.gov/pubmed/32542024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234236
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια